Add BrightSurf on Google Email

Another step toward an insulin tablet

Researchers have developed an orally administered tablet powered by chemical micromotors that deliver insulin to the colon, reducing blood glucose levels for over five hours. The mini-tablets protected from stomach acid and used hydrogen gas bubbles as micromotors to propel insulin into the bloodstream.

SourceAmerican Chemical Society·JournalACS Nano·DateJan 9, 2023

Microprotein increases appetite in mice

Researchers at Salk Institute discover thousands of previously unknown microproteins in brown and white fat tissue, finding that one, Gm8773, increases feeding activity in mice. This discovery could lead to the development of a therapeutic to promote weight gain in certain disease situations.

SourceSalk Institute·JournalCell Metabolism·DateJan 3, 2023

Where do reproductive-age women receive preventive health care?

A UMass Amherst study reveals that 61% of wellness visits for reproductive-age women (15-49) were with OB-GYNs, while chronic condition patients also relied heavily on these specialists. Key preventive services like pap tests and pelvic exams were more common in OB-GYN settings, whereas lipid testing was rare.

SourceUniversity of Massachusetts Amherst·JournalHealth Services Research·TypeData/statistical analysis·DateDec 22, 2022

Trigger in MODY3 diabetes: Insulin hypersecretion precedes pancreatic β cell failure

Researchers discovered that MODY3 patients experience hypersecretion of insulin from β cells due to more efficient membrane depolarization. This phenomenon precedes pancreatic β cell failure and can be targeted for prevention or delay with treatments, such as diets or drugs.

Research brief: Organizing care for diabetes patients during the COVID-19 pandemic

Researchers found that high-performing practices used proactive approaches to organize staff and manage patient interactions, leading to comprehensive addressing of patient care needs during in-person visits. The study suggests incorporating proactive patient care processes into primary care delivery to improve diabetes outcomes.

SourceUniversity of Minnesota Medical School·JournalPLOS ONE·TypeSurvey·DateDec 15, 2022

Detrimental secondary health effects after disasters and pandemics

Researchers at Osaka University found that disasters and pandemics increase major non-communicable diseases and mental disorders, especially among certain age groups. The study highlights the need for improved post-disaster health policies and prevention strategies to mitigate these effects.

SourceOsaka University·JournalInternational Journal of Disaster Risk Reduction·TypeObservational study·DateDec 15, 2022

Pollination loss removes healthy foods from global diets, increases chronic diseases causing excess deaths

A new study finds that inadequate pollination leads to a 3-5% loss of fruit, vegetable, and nut production, resulting in 427,000 excess deaths annually from lost healthy food consumption. The health burden is greater in middle- and higher-income countries with high rates of non-communicable diseases.

SourceHarvard T.H. Chan School of Public Health·JournalEnvironmental Health Perspectives·TypeComputational simulation/modeling·DateDec 14, 2022

Aging | The potential benefit of metformin to reduce delirium risk and mortality: a retrospective cohort study

A retrospective cohort study of 1,404 subjects with type 2 diabetes found that metformin use reduced the risk of delirium by 50% and decreased 3-year mortality rates. The study suggests that metformin may be a potential benefit for patients with diabetes, particularly in reducing age-related disorders such as dementia.

SourceImpact Journals LLC·JournalAging-US·TypeObservational study·DateDec 7, 2022

Oncotarget | Expression of p-STAT3 and c-Myc correlates with P2-HNF4α expression in nonalcoholic fatty liver disease (NAFLD)

Researchers found that P2-HNF4α expression is associated with p-STAT3 and c-Myc expression in NAFLD patients, suggesting potential biomarkers for hepatocellular carcinoma (HCC) risk. Additionally, p-STAT3 expression was linked to hypertension, while c-Myc expression was associated with advanced fibrosis.

SourceImpact Journals LLC·JournalOncotarget·TypeObservational study·DateDec 6, 2022

New mobile health technology for sleep apnea care to address individual patient needs

Researchers developed an app to track CPAP use, sleep patterns, and other health metrics to provide a new adherence metric that aligns therapy with individual need. This tool can help patients and providers deliver more effective sleep apnea treatment by tracking progress toward a personalized dose of therapy.

SourceUniversity of Chicago Medical Center·JournalJournal of Medical Internet Research·DateDec 5, 2022

Adoption of front-of-pack nutrition warnings can help decrease obesity, cardiovascular disease, type-2 diabetes and some cancers in the Americas

A recent study led by the University of Nevada, Reno and the Pan American Health Organization suggests that the adoption of front-of-pack nutrition labeling can help reduce poor-nutrition related non-communicable diseases in the region. Improved FOPNL systems have been associated with improved diet quality and reduced risk of NCDs.

SourceUniversity of Nevada, Reno·JournalThe Lancet Regional Health - Americas·DateDec 1, 2022

Finding the answers hidden in our antibodies

A new serological test, PepSeq, allows scientists to quickly test antibody binding against hundreds of thousands of protein targets, helping prepare for and respond to pandemics. The technology identifies specific antibodies that provide protection against infection, holding promise for developing effective vaccines and treatments.

SourceNorthern Arizona University·JournalNature Protocols·DateNov 30, 2022

The Green Mediterranean diet reduces twice as much visceral fat as the Mediterranean diet and 10% more than a healthy diet

A recent clinical trial found that the Green Mediterranean diet reduced visceral adipose tissue by 14%, outperforming both the traditional Mediterranean diet and a healthy diet. The new diet incorporates dietary polyphenols and lower red meat intake, resulting in significant weight loss benefits.

SourceBen-Gurion University of the Negev·JournalBMC Medicine·TypeRandomized controlled/clinical trial·DateNov 28, 2022

People with diabetes may benefit more from a pancreas transplant than other treatments

A new study published in the Journal of Clinical Endocrinology & Metabolism reveals that pancreas transplantation can provide up to 90% of recipients with diabetes freedom from insulin therapy and glucose monitoring. Despite high success rates, transplant numbers have declined due to lack of consensus criteria, education, and resource ...

SourceThe Endocrine Society·JournalThe Journal of Clinical Endocrinology & Metabolism·DateNov 15, 2022

Researchers studying new way to heal diabetic wounds by activating “hidden” mechanism in the body

Researchers have discovered a way to reactivate a fetal repair pathway in adults to improve healing of diabetic wounds. The study used tissue nanotransfection technology to deliver a gene that activates the protein NPGPx, which is active in fetuses but largely inactive in adults and absent in diabetic adults.

SourceIndiana University School of Medicine·JournalMolecular Therapy·DateNov 2, 2022

New onset chronic kidney disease in people with diabetes highest among ethnic, racial minorities

A study published in the New England Journal of Medicine found that new onset CKD rates are higher among Native Hawaiian/Pacific Islander, Black, American Indian/Alaska Native, and Hispanic/Latino populations compared to white persons with diabetes. The rate declined from 8% in 2015-2016 to 6.4% in 2019-2020.

SourceUniversity of California - Los Angeles Health Sciences·JournalNew England Journal of Medicine·TypeData/statistical analysis·DateOct 31, 2022

First medical guideline recommends new prescription medications for weight loss, ranks the most effective drugs

The American Gastroenterological Association releases new guidelines recommending medications paired with lifestyle changes for adults struggling to lose weight. The guidelines highlight the importance of treating obesity as a biological disease, reducing health complications like diabetes and fatty liver.

SourceAmerican Gastroenterological Association·JournalGastroenterology·DateOct 20, 2022

Smoking, diabetes and obesity – not preexisting heart disease – bigger risk of COVID-19 death, study finds

A national study found that patients with cardiovascular disease had a higher mortality rate than those without, but this association was largely due to shared risk factors. Myocardial injury was common among critically ill COVID-19 patients and associated with poor outcomes.

SourceMichigan Medicine - University of Michigan·JournalCirculation Cardiovascular Quality and Outcomes·TypeData/statistical analysis·DateOct 12, 2022

Providence study reveals high incidence of chronic kidney disease in diabetes beset by disparities

A study reveals a high incidence of chronic kidney disease among adults with diabetes, particularly affecting Native Hawaiian/Pacific Islander, Black, American Indian/Alaska Native, and Hispanic/Latino(a) groups. The rate of new onset CKD was higher in these groups by approximately 60%, 40%, 33%, and 25% compared to White persons with ...

SourceProvidence Health & Services·JournalNew England Journal of Medicine·TypeData/statistical analysis·DateOct 12, 2022

Cleveland Clinic researchers identify diabetes drug metformin as potential atrial fibrillation treatment in collaborative research

Researchers found that metformin targeted 30 genes associated with atrial fibrillation, showing direct effects on gene expression for eight. The study suggests metformin may be a promising candidate for treating atrial fibrillation due to its potential to reduce the risk of complications such as stroke and heart failure.

SourceCleveland Clinic·JournalCell Reports Medicine·DateOct 11, 2022